GenMark Diagnostics Shares Outstanding 2010-2019 | GNMK

GenMark Diagnostics shares outstanding from 2010 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
GenMark Diagnostics Annual Shares Outstanding
(Millions of Shares)
2018 56
2017 51
2016 44
2015 42
2014 41
2013 35
2012 26
2011 17
2010 10
2009 5
GenMark Diagnostics Quarterly Shares Outstanding
(Millions of Shares)
Q2 2019 57
Q1 2019 57
Q4 2018 56
Q3 2018 56
Q2 2018 56
Q1 2018 55
Q4 2017 51
Q3 2017 55
Q2 2017 48
Q1 2017 47
Q4 2016 44
Q3 2016 44
Q2 2016 43
Q1 2016 43
Q4 2015 42
Q3 2015 42
Q2 2015 42
Q1 2015 42
Q4 2014 41
Q3 2014 41
Q2 2014 41
Q1 2014 41
Q4 2013 35
Q3 2013 36
Q2 2013 32
Q1 2013 32
Q4 2012 26
Q3 2012 32
Q2 2012 21
Q1 2012 20
Q4 2011 20
Q3 2011 20
Q2 2011 14
Q1 2011 12
Q4 2010 12
Q3 2010 12
Q2 2010 9
Q1 2010 7
Q4 2009 5
Q3 2009 5
Q2 2009 4
Q1 2009 4
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.345B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $118.240B 25.19
Intuitive Surgical (ISRG) United States $61.021B 53.37
Edwards Lifesciences (EW) United States $44.736B 43.54
IDEXX Laboratories (IDXX) United States $23.571B 59.13
Fresenius Medical Care AG KGaA (FMS) Germany $21.210B 14.24
Olympus (OCPNY) Japan $17.714B 133.03
Teleflex (TFX) United States $15.798B 33.53
SONOVA HOLDING (SONVY) Switzerland $14.350B 0.00
Sysmex ADR (SSMXY) Japan $14.145B 38.13
DexCom (DXCM) United States $14.133B 209.45
Hologic (HOLX) United States $13.365B 21.10
STERIS (STE) Ireland $12.346B 28.48
Varian Medical Systems (VAR) United States $10.559B 25.26
ABIOMED (ABMD) United States $8.727B 49.95
Masimo (MASI) United States $8.081B 49.03
SARTORIUS AG (SARTF) Germany $5.614B 49.88
Integra LifeSciences Holdings (IART) United States $5.208B 23.24
Penumbra (PEN) United States $5.143B 184.76
Globus Medical (GMED) United States $5.089B 32.30
Elekta AB (EKTAY) Sweden $5.065B 38.99
LivaNova (LIVN) United Kingdom $3.820B 29.13
Cantel Medical (CMD) United States $3.717B 37.71
Tandem Diabetes Care (TNDM) United States $3.610B 0.00
Nevro (NVRO) United States $2.758B 0.00
Wright Medical Group (WMGI) Netherlands $2.688B 235.78
Glaukos (GKOS) United States $2.645B 0.00
Integer Holdings (ITGR) United States $2.598B 18.38
Nihon Kohden (NHNKY) Japan $2.483B 24.98
AVANOS MEDICAL, INC (AVNS) United States $1.748B 32.42
Veracyte (VCYT) United States $1.262B 0.00
OPKO Health (OPK) United States $1.262B 0.00
Accelerate Diagnostics (AXDX) United States $1.160B 0.00
Silk Road Medical (SILK) United States $1.103B 0.00
CryoLife (CRY) United States $1.086B 103.39
Inogen (INGN) United States $1.077B 26.39
Natus Medical (NTUS) United States $1.060B 24.69
Luminex (LMNX) United States $0.999B 0.00
Mesa Laboratories (MLAB) United States $0.995B 45.99
ORTHOFIX MEDICAL INC (OFIX) United States $0.978B 30.71
Tactile Systems Technology (TCMD) United States $0.941B 116.21
Corindus Vascular Robotics (CVRS) United States $0.885B 0.00
Pacific Biosciences Of California (PACB) United States $0.864B 0.00
AngioDynamics (ANGO) United States $0.701B 22.82
OrthoPediatrics (KIDS) United States $0.578B 0.00
Intersect ENT (XENT) United States $0.572B 0.00
AxoGen (AXGN) United States $0.558B 0.00
Quotient (QTNT) Switzerland $0.535B 0.00
Si-Bone (SIBN) United States $0.488B 0.00
Fluidigm (FLDM) United States $0.403B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.379B 14.56
Alphatec Holdings (ATEC) United States $0.352B 0.00
Sientra (SIEN) United States $0.344B 0.00
ViewRay (VRAY) United States $0.336B 0.00
Semler Scientific (SMLR) United States $0.290B 48.90
Stereotaxis (STXS) United States $0.282B 0.00
Accuray (ARAY) United States $0.257B 0.00
IRadimed (IRMD) United States $0.255B 42.40
SeaSpine Holdings (SPNE) United States $0.231B 0.00
RTI Surgical (RTIX) United States $0.229B 34.44
CRH Medical (CRHM) Canada $0.216B 75.00
Neuronetics (STIM) United States $0.196B 0.00
TransEnterix (TRXC) United States $0.154B 0.00
ConforMIS (CFMS) United States $0.133B 0.00
EDAP TMS S.A (EDAP) France $0.129B 63.57
T2 Biosystems (TTOO) United States $0.128B 0.00
Second Sight Medical Products (EYES) United States $0.115B 0.00
Sensus Healthcare (SRTS) United States $0.101B 0.00
Apollo Endosurgery (APEN) United States $0.072B 0.00
Spectral Diagnostics (EDTXF) Canada $0.071B 0.00
Electromed (ELMD) United States $0.053B 27.09
Vermillion (VRML) United States $0.052B 0.00
Helius Medical Technologies (HSDT) United States $0.046B 0.00
Bioanalytical Systems (BASI) United States $0.040B 0.00
Ekso Bionics Holdings (EKSO) United States $0.039B 0.00
Xtant Medical Holdings (XTNT) United States $0.032B 0.00
Neovasc (NVCN) Canada $0.031B 0.00
Restoration Robotics (HAIR) United States $0.026B 0.00
Nuvectra (NVTR) United States $0.026B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.023B 0.00
ReWalk Robotics (RWLK) Israel $0.023B 0.00
Ra Medical Systems (RMED) United States $0.019B 0.00
DarioHealth (DRIO) Israel $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.014B 20.33
Lianluo Smart (LLIT) China $0.013B 0.00
OBALON THERPTCS (OBLN) United States $0.012B 0.00
Cesca Therapeutics (KOOL) United States $0.012B 0.00
Nanovibronix (NAOV) United States $0.011B 0.00
Dynatronics (DYNT) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.009B 0.00
Avinger (AVGR) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Allied Healthcare Products (AHPI) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.004B 0.00
Viveve Medical (VIVE) United States $0.000B 0.00